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Summary
Throughout lymphocyte development, cellular persis-
tence and expansion are tightly regulated by survival
and apoptosis. Within the Bcl-2 family, distinct apop-
togenic BH3-only members like Bid, Bim, and Puma
appear to function in specific cell death pathways.
We found that naive human T cells after mitogenic
activation, apart from expected protective Bcl-2 mem-
bers, also rapidly upregulate the BH3-only protein
Noxa in a p53-independent fashion. The specific role
of Noxa became apparent during glucose limitation
and involves interaction with the labile Bcl-2 homolog
Mcl-1. Knockdown of Noxa or Mcl-1 results in protec-
tion or susceptibility, respectively, to apoptosis in-
duced by glucose deprivation. Declining Mcl-1 levels
and apoptosis induction are inversely correlated to
Noxa levels and prevented by readdition of glucose.
We propose that the Noxa/Mcl-1 axis is an apoptosis
rheostat in dividing cells, in a selective pathway that
functions to restrain lymphocyte expansion and can
be triggered by glucose deprivation.
Introduction
Throughout their lifespan, T lymphocytes receive vari-
ous environmental cues that determine their survival or
elimination by two major apoptosis pathways, the ‘‘ex-
trinsic’’ and ‘‘intrinsic’’ pathways (Marsden and Strasser,
2003). The extrinsic pathway is triggered via death re-
ceptors such as CD95, which activates caspase-8 via
its adaptor FADD (Medema et al., 1997). The intrinsic
pathway of apoptosis responds to a wide variety of
stress signals and culminates in release of, among
others, cytochrome C (cytC) from mitochondria. A con-
nection between these pathways is formed by Bid,
which is activated upon cleavage by caspase-8. Mito-
chondrial integrity is controlled by the Bcl-2 family of
proteins, which can be divided into antiapoptotic Bcl-
2-like proteins and proapoptotic Bax-like proteins. A
third group within the Bcl-2 family consists of so-called
BH3-only proteins, which includes Bid, Bim, Noxa, Hara-
kiri, and Puma, and acts as initiators of programmed
cell death (Strasser, 2005). By forming heterodimeric
complexes at the mitochondria, Bcl-2 family members
determine mitochondrial integrity and either promote
or suppress apoptosis.
*Correspondence: e.eldering@amc.uva.nlRecent reports demonstrated that the function of and
interactions between the members of the Bcl-2 family
are restricted, thereby also providing information on
how Bax and Bak are triggered (Kuwana et al., 2005;
Chen et al., 2005). Bid and Bim are apparently the only
BH3-only proteins that can directly interact with Bax.
Others, like Bad, Puma, and Noxa, work indirectly via
‘‘sensitization’’ or ‘‘derepression’’ and interact only with
protective Bcl-2-like members. The challenge now is
to translate these protein interaction data into actual
apoptosis-signaling pathways operating on cells during
distinct differentiation processes.
At early differentiation steps in the thymus, T cell sur-
vival or death are determined by the proper rearrange-
ment of antigen receptor genes and by the presence of
the cytokine IL-7. At this stage, T cell fate is mainly reg-
ulated by the mitochondrial pathway, although death
receptor signaling appears also to contribute to the
deletion of precursor T cells (Akashi et al., 1997; Kabra
et al., 2001; Rathmell et al., 2002; Bouillet et al., 2002; Vil-
lunger et al., 2004). Subsequently, mature naive T cells
are released in the periphery where interactions with
self-MHC/peptide molecules and the gc cytokines IL-7
and IL-15 are key factors regulating mature T cell ho-
meostasis (Marrack and Kappler, 2004). In the periph-
ery, naive T cells patrol secondary lymphoid organs until
they encounter their cognate antigen and become acti-
vated. The subsequent massive cell death of effector-
type cells depends on BH3-only member Bim (Pellegrini
et al., 2003; Hildeman et al., 2002). In addition, the death
receptor pathway is also involved in mature lymphocyte
biology, as homeostasis of chronic immune-activated
T cells in vivo depends on CD95 (Arens et al., 2005).
Of particular interest is the moment of T cell priming.
At this point, cell numbers increase dramatically under
rapidly changing conditions. The contribution of costi-
mulatory receptors such as CD28 at this stage is rela-
tively well documented and known to involve induction
of various protective Bcl-2 family members, such as
Bcl-2, Bcl-xL, A1/Bfl-1 (Gonzalez et al., 2003; Kerstan
and Hunig, 2004; Verschelde et al., 2003; Burr et al.,
2001). This group, also including Mcl-1 and Bcl-w,
seems to possess largely overlapping survival functions
as inhibitors of cytochrome C release from mitochondria
(Strasser, 2005). From this viewpoint, it is not obvious
why cells require a tightly regulated system of multiple
analogous proteins. Therefore, it may well be that
more upstream in the cascade leading to apoptosis
the decision is made how different signals couple to
the distinct Bcl-2 family members.
In accord with this line of reasoning and with the re-
cent biochemical interaction data mentioned above,
the various members of the BH3 domain-only group dif-
fer strikingly in their responsiveness to stimuli and con-
sequently in the pathways they can regulate (Strasser,
2005). For instance, Puma is transcriptionally upregu-
lated upon p53 activation, Bim binds to the cytoskeleton
and is released upon growth factor withdrawal, while
Bid is processed and activated by caspase-8, down-
stream from death receptors. Noxa was also described
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704as a p53-responsive gene (Oda et al., 2000), but subse-
quent mouse knockout studies have indicated that Noxa
differs functionally from Puma (Villunger et al., 2003), so
its current status is uncertain. Likewise, the case for Bim
seems not airtight, as later it was shown to be under
transcriptional regulation, especially in conditions of
chronic activation in vitro (Sandalova et al., 2004).
Thus, on closer inspection and at the level of complex
cellular interactions, there are gaps in our understanding
of specific contributions of the BH3-only members.
In order to close these gaps in understanding and to
address current controversies concerning the contribu-
tions of the various BH3-only and protective Bcl-2 family
members, we initiated a comprehensive expression
analysis of apoptosis regulators in human naive CD4+
and CD8+ T cells after mitogenic activation via either
TCR/CD3 or common g-chain containing cytokine re-
ceptors. In addition to the expected upregulation of pro-
tective Bcl-2 members, we observed a strict regulation
of Noxa upon T cell activation and expansion, suggest-
ing that this prepares the cell for a selective event. The
role of Noxa becomes apparent under glucose depriva-
tion and/or nutrient stress and involves interaction with
the labile Bcl-2 homolog Mcl-1. We infer that the Noxa/
Mcl-1 axis is a crucial player under competitive condi-
tions in dividing cells.
Results
Simultaneous Induction of Noxa and Antiapoptotic
Members in Naive T Cells after TCR/CD28 Activation
The RT-MLPA procedure affords an effective means to
quantify the relative expression of 34 important regula-
tors of apoptosis, mostly members of the Bcl-2 and
IAP families (Eldering et al., 2003; Kater et al., 2004).
The specificity and sensitivity of this multiplex proce-
dure to reliably quantify changes in gene expression
patterns has been demonstrated elsewhere (Mackus
et al., 2005). To analyze the first phase of priming of
naive T cells concerning proliferation, viability, and apo-
ptosis gene expression pattern, we compared naive
CD8 and CD4 T cells at different time points (t = 24, 72,
120 hr) after either single TCR or combined TCR and
CD28 stimulation. Proliferation and apoptosis parame-
ters, as determined by CFSE labeling and Annexin-V
staining, respectively, are presented in Figures S1A
and S1B in the Supplemental Data available with this
article online. Proliferation became evident at day 3 for
both CD3 and CD3/CD28 stimulation, with the latter dis-
playing more divisions at that time point. Over the 5 day
period, the viability of control and stimulated cells re-
mained >75%. The expression of the apoptosis gene
set was determined via the RT-MLPA procedure, and
the differential expression ratio was determined for all
target genes (see Figures S1 and S2 for further details).
The kinetics for a set of genes differentially regulated in
activated CD8+ and CD4+ T is shown in Figures 1A and
1B, respectively. Stimulation via CD28 only did not
induce significant changes in expression pattern com-
pared to unstimulated cells (data not shown). The
CFSE pattern (see Figure S1) correlated with the expres-
sion of Survivin (Figure 1), a protein regulated in a cell cy-
cle-dependent manner (Li et al., 1998). For CD8 and CD4
T cells, a rapid and transient induction of antiapoptoticmembers (Bcl-2, Bcl-xl, and Bfl-1) was observed after
immune activation. In addition, for CD8+ T cells, a syner-
gistic effect of CD28 triggering was detected on TCR-in-
duced Bcl-xl and Bfl-1 upregulation, but for Bcl-2 this
was the reverse, and higher induction was noted after
single TCR triggering. Unexpectedly, the BH3-only
member Noxa was rapidly upregulated and maintained
after TCR/CD28 stimulation in both CD4 and CD8 sub-
sets. This induction was clearly CD28 independent for
CD8+ T cells. None of the other BH3-only members
were induced specifically by TCR stimulation (see
Figure S2 and legend for further details).
Thus, a limited set of the apoptotic genes analyzed are
regulated during the initial stage of naive T cell activa-
tion. Apart from the expected transient upregulation of
antiapoptotic genes of the Bcl-2 family, RT-MLPA anal-
ysis revealed that Noxa is rapidly induced and main-
tained upon TCR triggering.
Noxa Is Induced via TCR Triggering in a Reversible
Manner, Mediated via PKC
The RT-MLPA data were validated by RT-PCR analyses
for Noxa transcripts in naive and activated CD8+ T cells.
As depicted in Figure 2A (top), Noxa mRNA was induced
specifically after TCR stimulation, and simultaneous
CD28 triggering had no extra effect. Concomitant pro-
tein analyses showed that the induction of Noxa corre-
lated with the increased levels of mRNA observed after
TCR activation. On the protein level, there seemed to
be a posttranscriptional additional effect of CD28 costi-
mulation (Figure 2A, bottom). These results were con-
firmed in activated naive CD4+ T cells (data not shown).
Noxa induction was reversible, as shown by washing
and reculturing CD8 T cells after prior CD3 stimulation.
After 2 days rest, the Noxa PCR product was decreased
to prestimulation levels, and restimulation via CD3 again
resulted in upregulation (Figure 2B). Together, these re-
sults demonstrate that TCR engagement induces Noxa
expression at both mRNA and protein level and that
continuous TCR triggering is required to sustain Noxa
expression.
Since Noxa induction in naive CD8+ T cells required
TCR stimulation only without additional CD28 triggering,
experiments investigating the intracellular signaling
pathway were performed with naive CD8+ T cells, stim-
ulated for 24 hr via the TCR. Various pharmacological
inhibitors that specifically block different signal trans-
duction components were used at a concentration that
blocks TCR-induced proliferation of CD8+ T cells (data
not shown). The inhibition of several signaling transduc-
tion molecules downstream of the TCR such as MEK1/2,
p38, PI3 kinase, Calcineurin, or NFkB, via PD98059,
SB202190, LY294002, cyclosporine, and NFkBay, re-
spectively, did not affect TCR-induced Noxa expres-
sion. Noxa expression was, however, clearly abrogated
via a low concentration of staurosporine (Figure 2C). We
have shown before that at low concentrations, stauro-
sporine is a nonspecific PKC inhibitor and blocks prolif-
eration (van Lier et al., 1991). Hence, we broadened
the panel of different specific PKC inhibitors via bisindo-
lylmaledeide (BIM) and rottlerin. Indeed, when naive
CD8+ T cells were activated in the presence of these
specific PKC inhibitors, TCR-induced Noxa expression
was precluded. The same results were obtained with
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705Figure 1. Bcl-2 Family Gene Expression of
Naive T Cells after Combined TCR and
CD28 Costimulation
Naive CD8+ (top) or CD4+ (bottom) T cells
were left unstimulated (triangles) or stimu-
lated by either anti-CD3 Ab (squares) or the
combination of anti-CD3 Ab + anti-CD28 Ab
(diamonds) for 24, 72, and 120 hr. At the des-
ignated time points, cells were harvested, to-
tal RNA was immediately isolated, and RT-
MLPA was performed. Averaged expression
profile for three different time points is de-
picted. The fold induction (mean 6 SD from
three experiments) for each gene was quanti-
fied as expressed in comparison to the value
obtained from unstimulated cells (t = 24 hr).naive CD4+ T cells (data not shown). In support of PKC
involvement, Noxa expression was also induced after
activation with the accepted PKC activator PMA, but
not with the Ca2+ ionophore ionomycine (Figure 2D).
TCR-Induced NOXA Expression Is p53 Independent
It has been reported previously that Noxa and Puma,
two BH3-only members of the Bcl-2 family, are p53 tar-
get genes (Oda et al., 2000; Villunger et al., 2003; Nakano
and Vousden, 2001). Thus, the expression of Noxa and
Puma was compared via the RT-MLPA procedure
upon TCR stimulation or g-irradiation in CD8+ T cellsthat have a p53-deficient response. Primary CD8+ T cells
were retrovirally transduced with either GFP only or GFP
plus a p53 RNAi-targeting sequence (p53i cells), and
>90% GFP+ transduced cells were obtained via FACS
sorting. These p53i cells exhibit impaired p53 protein
upregulation after g-irradiation (Gimeno et al., 2004).
The viability of mock transduced and p53i cells was
compared upon CD3 stimulation and irradiation (Fig-
ure 3A). Whereas in control cells massive cell death
was observed after irradiation, p53i cells were clearly
impaired in this classical p53-mediated response. The
results of RT-MLPA analyses for Noxa and Puma are
Immunity
706Figure 2. Specific Induction of Noxa at mRNA and Protein Level
after TCR Signaling Is Prevented by PKC Inhibitors
(A) Naive CD8+ T cells were analyzed immediately after isolation
(naive), left unstimulated (medium), or stimulated with the indicated
Abs. Top: total RNA was obtained and subjected to RT-PCR con-
firming Noxa induction after CD3 and CD3/CD28 triggering for 3
days. Bottom: in the same samples, Noxa protein expression was
analyzed by Western blot. Data are representative of three experi-
ments performed.
(B) Noxa mRNA expression was analyzed in unstimulated cells,
in cells stimulated with anti-CD3 Ab for 3 days (CD3 (d3), in cells
subsequently washed and cultured for an additional 2 days (CD3
(d3)+ rest (d2)), and in cells restimulated for 1 day with anti-CD3
Ab (restim.CD3(d1).
(C) Naive CD8+ T cells were stimulated with the plate bound anti-CD3
Ab for 24 hr in the presence of different signaling transduction inhib-
itors. Total RNA was obtained and subjected to RT-PCR analysis for
Noxa transcript. Different intracellular signaling pathway inhibitors
were tested (from left to right): no treatment, PI3 kinase inhibitor
(10 mM), MAP kinase inhibitor (10 mM), p38 inhibitor (10 mM), NFkB
inhibitor (Rathmell et al., 2002), staurosporine (10 nM), and cyclo-
sporine (500 ng/ml).
(D) PKC-dependent induction of Noxa. Naive CD8+ T cells were left
unstimulated or stimulated with the plate bound anti-CD3 Ab for
24 hr in the presence of different PKC inhibitors (from left to right):
no treatment, CD3-stimulated, CD3-stimulated + staurosporine
(10 nM), CD3-stimulated + BIM (0.2 mM), CD3-stimulated + rottlerin
(10 mM). In parallel, cells were stimulated with PMA (1 ng/ml), iono-
mycin (1 mg/ml), or combined PMA and ionomycin for 4 hr. Data
are representative of three experiments performed.shown in Figure 3B. Similar to untransduced naive cells,
Noxa but not Puma was induced in these CD8+ T cells
after TCR triggering. Conversely, irradiation of CD8+ T
cells did not upregulate Noxa while Puma was induced,
Figure 3. Noxa Induction in Human Lymphocytes Is p53 Indepen-
dent
(A) CD8+ T cells expressing control-GFP (gray bars) or CD8+ T cells
expressing p53i construct (black bars) were left unstimulated, stim-
ulated with anti-CD3 Ab (1 mg/ml) for 24 hr, or g-irradiated. At the
designated time point, cell viability was analyzed by FACS (annexin
V/PI staining).
(B) Noxa (top) and Puma (bottom) mRNA expression was analyzed
by RT-MLPA.
(C) Noxa expression was analyzed by Western blot in control or p53i
CD8+ T cells. Data are representative of two experiments performed.
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cells, demonstrating that Puma is a bona fide p53 target
gene. Similar results were obtained after treatment with
etoposide and fludarabine (data not shown). Moreover,
protein analysis revealed that Noxa levels were equiva-
lently upregulated in control and p53-deficient cells after
TCR triggering, but not upon irradiation (Figure 3C).
Together, these data indicate that in human lympho-
cytes, TCR-induced Noxa expression is regulated in a
p53-independent manner.
Noxa Is Expressed in Activated or Highly
Dividing Cells
Thus far, we established that Noxa was induced early in
TCR-activated T cells in a p53-independent manner. Our
previous work showed that especially IL-7 but also IL-15
are able to induce activation and cell division in naive
CD8+ T cells in an antigen-independent manner (Alves
et al., 2003, 2005). Hence, we analyzed whether these
gc cytokines induced expression of Noxa in naive T cells.
As depicted in Figure 4A, activation of naive CD4+ or
CD8+ T cells with IL-7 or IL-15 for 24 hr induced Noxa
expression simultaneously with upregulation of Bcl-2,
similar to TCR/CD28 stimulation. These data suggested
that any mitogenic stimulation might, independently of
p53 activation, be associated with Noxa expression in
T cells. In line with this, Noxa levels were indeed elevated
in human acute T lymphoblastic leukemia Jurkat cells
(clone J16; Werner et al., 2002). In these p53-deficient
cells, Noxa expression also coincided with high cycling
status and high levels of survivin. In fact, the expression
pattern of the entire Bcl-2 family of Jurkat J16 cells re-
sembled to a significant extent that of activated primary
CD8+ T cells (Figure 4B). One conspicuous difference
was the level of Bid, in accord with the high sensitivity
to CD95-mediated apoptosis of Jurkat. Another was
the induced expression of A1/Bfl1 in activated T cells,
a known binding partner of Bid (Werner et al., 2002;
Chen et al., 2005). Furthermore, Noxa expression was
detected at increased values in all lymphoid and non-
lymphoid malignant cell lines tested (B cells, myeloid
leukemia, osteosarcoma, neuroblastoma; see below
and data not shown). In contrast, in noncycling primary
T cells, Noxa levels as detected by MLPA were negligible
or absent.
Noxa Confers Susceptibility to Apoptosis under
Selective Stressed Conditions Provoked
by Glucose Limitation
To study Noxa function in dividing cells, Jurkat J16 were
transduced with retroviral vectors expressing Noxa
siRNA or a control-GFP virus (Brummelkamp et al.,
2002). Only 2 out of 10 siRNA constructs tested signifi-
cantly reduced endogenous Noxa protein expression
(25%–50% of levels in mock-transduced cells; Fig-
ure 5Ai). The specificity of RNAi constructs was also
evaluated via MLPA, confirming that among the 34 apo-
ptosis genes, Noxa was specifically targeted (Figure S3).
Parental J16, GFP cells, or cells with low levels of Noxa
(N7 or N8) were compared after a variety of well-known
death stimuli that trigger either death receptors (CD95),
the TCR, mitochondria (serum deprivation, etoposide,
taxol, H2O2, CCCP), or the ER pathway (thapsigargin).
No significant effect of reduced Noxa levels wereFigure 4. Noxa Is Expressed in Human Dividing T Lymphocytes
(A) Induction of Noxa in naive T cells after stimulation with gc cyto-
kines. Naive CD4+ or CD8+ T cells were left unstimulated or stimu-
lated with IL-7 and IL-15 for 24 hr. Noxa and Bcl-2 mRNA expression
was analyzed by RT-MLPA.
(B) Noxa is highly expressed in dividing Jurkat cells. mRNA was iso-
lated from Jurkat and CD8+ T cells stimulated via CD3/CD28 for 5
days (see also Figure 1). Apoptotic gene expression profile analyzed
by RT-MLPA. Top, BH3-only members; bottom, protective members
and Bax-like members; survivin is represented as indication of the
cell cycle status of cells.
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(A) (i) Noxa knockdown was obtained with two different Noxa siRNA constructs. Jurkat T cell line was transduced with pRetro-control GFP (M),
pRetro-GFPsiNoxa6 (N6), pRetro-GFPsiNoxa7 (N7), and pRetro-GFPsiNoxa8 (N8). J16 (untransduced cells). (ii) Improved knockdown was
achieved by performing a limiting dilution from the bulk N8 population. Total cell lysates derived from GFP+ cells were separated by SDS-
PAGE, and Noxa protein levels were monitored by immunoblotting. Actin serves as a loading control.
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a control, an antagonistic antibody against CD95 was
applied to block CD95-mediated apoptosis, as well as
TCR-mediated apoptosis. This confirmed the reported
involvement of CD95 triggering in the TCR-apoptosis
pathway in Jurkat cells (Dhein et al., 1995) and showed
that Noxa does not play a role in this model of activa-
tion-induced cell death (AICD). Next, assuming that
Noxa might function in dividing cells in situations of
cellular stress that deviate from the usual steady-state
culture conditions, a competitive outgrowth assay was
performed. GFP+ (Noxa high) or GFP+ N7 or N8 (Noxa
low) cells were mixed in a 1:1 ratio with untransduced
GFP2 Jurkat cells (Noxa high) at initial standard cell den-
sity (0.3 3 106 cells/ml) and maintained up to 8 days
without medium refreshment. Over time, the percentage
of apoptosis and the ratio between GFP+ or GFP+ N7/N8
cells over normal GFP2 J16 cells was determined in the
total population and in the viable cells, respectively. To-
tal cell numbers increased equally in all conditions up to
day 4–5 (data not shown). From the moment cells under-
went apoptosis (day 4–5), lower levels of Noxa clearly
conferred a competitive advantage under these condi-
tions of high density and cell stress (Figure 5B, left).
This was most clear for the N8 construct that reduced
Noxa protein to an estimated 25% (see Figure 5Ai). In
the viable cell population, a prominent increase in ratio
of Noxa N7 or N8 over J16 cells was observed that
matched the level of Noxa protein knockdown (Figures
5Ai, 5B, 5C, and 5D, left). In order to rule out that the
survival advantage of Noxa low cells was an exclusive
feature of Jurkat cells, similar experiments were per-
formed with Ramos Burkitt lymphoma B cells express-
ing the Noxa N7 and N8 constructs. Again, a competitive
advantage for cells with reduced Noxa was observed
(Figure S5), suggesting a general role for Noxa in these
circumstances.
The previous experiments were performed in IMDM
with high glucose and nutrient content. Glucose is an im-
portant nutrient in cell metabolism of highly proliferative
lymphocytes as a source of energy and providing pre-
cursors for biosynthesis (Frauwirth and Thompson,
2004; Frauwirth et al., 2002). To test whether Noxa was
involved in cell death mediated via glucose deprivation,
similar experiments were performed in DMEM without
pyruvate and in physiological concentrations of glucose
(5 mM). Under these conditions, cell numbers increased
in all three populations up to day 4, and as expected cell
death occurred earlier (2–3 days), when glucose became
depleted in the medium (data not shown). Consistently,the survival advantage of Noxa-deficient cells recurred.
Moreover, addition of exogenous glucose (5 mM) on day
2 not only postponed cell death, but also the selective
advantage of cells with low Noxa was maintained (Fig-
ures 5B, 5C, and 5D, middle).
The correlation between Noxa levels and susceptibil-
ity to apoptosis under glucose-deprived conditions was
substantiated by further reduction in Noxa content. By
a limiting dilution assay from the N8 parental population,
several clones were obtained with increased Noxa
knockdown (N8.11, N8.15, N8.25) (Figure 5Aii). The over-
all apoptotic expression profile of these clones was also
evaluated via MLPA, confirming the similarity to the
parental N8 cells, apart from further reduction in Noxa
mRNA levels (data not show). Competitive outgrowth
assays demonstrated that an additional decrease in
Noxa protein levels (Figure 5Aii) resulted in an improved
survival of cells during glucose starvation. This is dem-
onstrated by superior cell ratios that approached 1:10
and showed increased differences in survival curves
(Figures 5B, 5C, and 5D, right). In Figure 5D (right), the
increased survival as expressed by cell ratios in several
clones with improved Noxa knockdown is shown. In ad-
dition, the decreased ratio in a clone where Noxa levels
were found to be increased are included (clone N8.8, see
also Figure 5Aii). Thus, these data indicated that Noxa
protein level is correlated with cell death induced by
glucose limitation.
Next, the effect of Noxa knockdown was investigated
in primary T cells undergoing TCR stimulation. Cells
from various donors were virally transduced with the
N8 construct and sorted to homogeneity; the yield of
GFP+ cells ranged from 1 to 4 3 105 per donor. Initially,
primary lymphocytes were expanded to yield sufficient
cell numbers to perform functional assays (as described
in Experimental Procedures section). The expected re-
duction in Noxa protein expression upon TCR stimula-
tion is shown in Figure 6A. Upon TCR stimulation and
proliferation, cells were tested under various selective
conditions. Analogous to the situation in Jurkat cells,
stimuli such as mitochondrial membrane depolarization
(CCCP) or g-irradiation did not provide a survival advan-
tage in primary T cells upon Noxa RNAi. Stimulation via
the TCR in complete medium or in absence of serum,
which can trigger activation-induced cell death (AICD)
in this context, did not reveal a survival advantage of
cells with low Noxa (Figure 6B, middle). These experi-
ments indicated that Noxa, although induced by TCR
triggering in primary T cells, was not involved in the ac-
tual execution of TCR-mediated apoptosis in chronically(B) Reduction in Noxa levels confers a competitive advantage under glucose limitation. Untransduced J16 cells (GFP2) were mixed initially at
1:1 ratio with either M, N7, or N8 J16 GFP+ cells and cultured more than 1 week in medium supplemented with 25 mM or 5 mM glucose. At
the designated time points, populations were analyzed by FACS first in the live gate and second based on GFP expression. Note that this
way of analysis was required since apoptotic cells leak GFP protein. Shown are representative experiments when J16 were mixed with either
N8 cells (25 mM glucose, left; and 5 mM glucose, middle) or N8.25 cells (5 mM glucose, right).
(C) Survival of Noxa high (J16-GFP2) and Noxa low (N7/8-GFP+) cells during growth. Cell viability was measured based on the percentage of
GFP2 or GFP+ cells found within the total viable population: top left and middle panel, J16 (circles) and N7 (squares) cells; lower left and middle
panel, J16 (circles) and N8 (diamonds) cells. Dashed lines with open symbols represent correspondent populations in cultures supplemented
with extra 5 mM glucose on day 2. Top right, J16 (circles) and N8.15 (triangles); lower right, J16 (circles) and N8.25 (diamonds).
(D) The ratio between transduced (GFP+) and untransduced (GFP2) cells was calculated in the live gating. Left and middle, M (M:J16) (circles), N7
(N7:J16) (squares), and N8 (N8:J16) (diamonds). Dashed lines with open symbols represent correspondent ratios in cultures supplemented with
extra 5 mM glucose on day 2. Right, untransduced (GFP2) cells were mixed with either parental N8 (N8p) (open diamonds), N8.8 (squares), N8.11
(circles), N8.15 (triangles), or N8.25 (filled diamonds). Note that the y axis increases in scale in left, middle, and right, respectively. Data represent
mean 6 SD from three experiments.
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Limitation
(A) Primary T cells were retrovirally transduced with control GFP or
N8 constructs, and after sorting to homogeneity, resting or 24 hr
CD3/CD28-stimulated cells were tested for Noxa expression. A
reduction in Noxa expression was clearly observed in the N8 cells.
(B) Top: after transduction and sorting in GFP+Mock (M) and GFP+N8
(N8) populations, primary T cells were treated for 24 hr with 25 mM
CCCP to uncouple mitochondrial respiration and thereby triggeractivated cells, similar to the findings in Jurkat cells (see
Figure S4). In contrast, experiments with proliferating
cells in 1 mM glucose showed that a competitive advan-
tage of cells transduced with the N8 construct versus
the control could be observed. Increased ratios of cells
with low Noxa over control cells undergoing apoptosis
were found, as illustrated after 2 days stimulation in
Figure 6B (bottom). Viability and cell ratios were not
altered when Mock (GFP+) cells were mixed with un-
transduced cells (data not shown). Thus, also in primary
cells where Noxa is expressed only upon activation,
a specific role of Noxa in survival under glucose limita-
tion was observed.
Noxa Functions under Specific Conditions
of Mcl-1 Reduction
Recent biochemical studies indicate that BH3-only pro-
teins differentially bind protective Bcl-2 members. In
particular, Noxa associates exclusively with Mcl-1 and
Bfl-1 (Chen et al., 2005; Kuwana et al., 2005). Given the
almost undetectable levels of Bfl-1 in Jurkat cells (Fig-
ure 4B), Noxa might be associated with Mcl-1. Coimmu-
noprecipitation assays indeed demonstrated that in
healthy Jurkat cells almost all Noxa protein was associ-
ated with Mcl-1. The known association of Mcl-1 with
Bim was also confirmed (Figure 7A). Crude cellular frac-
tionation into cytoplasmic, light, and heavy membrane
fractions showed that virtually all Mcl-1 and Noxa pro-
tein resided in the heavy membrane fraction (Figure 7B),
which is enriched for mitochondria but may also contain
contaminating rough ER.
The Mcl-1-Noxa interaction implied that Noxa func-
tion may coincide with decreasing Mcl-1 levels. Accord-
ingly, cell lysates obtained from Jurkat cells cultured
in 25 mM or 5 mM glucose showed a clear reduction in
Mcl-1 protein levels concomitant with appearance of
cell death. Both apoptosis and the decline in Mcl-1
were delayed when exogenous glucose was supple-
mented on day 2 (Figure 7C, bottom right). Strikingly,
the reduction in Mcl-1 appeared to match the degree
of Noxa knockdown. This was particularly noticeable
at day 7 and day 4 when cells were cultured in 25 and
5 mM glucose, respectively. Concurrent with the drop
in Mcl-1 protein, Noxa levels were reduced, suggesting
that both were subject to increased degradation under
these conditions (Figure 7C).
To confirm the functional link between Noxa and
Mcl-1, the endogenous expression of Mcl-1 protein
was targeted by two distinct siRNA vectors. A substan-
tial reduction of Mcl-1 protein was achieved in particular
with the Mcl-1i.1 construct (Figure 7Di). Competitive
apoptosis or with g-radiation (5 Gy). Competitive assay (middle
and bottom): GFP+ N8 cells (N8) were mixed in a 1:1 ration with
sorted GFP2 cells that underwent the same treatment (C), in com-
plete medium containing 10% or 0% FCS. After restimulation via
the CD3+CD28, cells were analyzed for viability at day 0 and day 2.
Bottom: cells from two donors were mixed in a 1:1 ratio and trig-
gered via CD3 and CD28 in medium containing low glucose (1 mM)
and compared for viability at day 0 and day 2. Cells were scored
for viablity: at top presented as % viable cells in the separate cul-
tures; in the middle and bottom panels is presented the % of Noxa
high (GFP2) or low (GFP+) cells within the viable gate in the mixed
cultures. Numbers indicate the ratios between N8 and C cells in
two separate experiments.
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Mcl-1 rendered cells more susceptible to apoptosis
in glucose-limited conditions (Figures 7Dii and 7Diii), re-
sulting in an inverse phenotype of the cells with Noxa
knockdown. Moreover, readdition of glucose at day 2
again delayed apoptosis in this setting (data not shown).
In conclusion, these experiments in cells with reduced
Noxa or Mcl-1 levels indicated that this protein pair func-
tions specifically under conditions of overgrowth and
glucose limitation.
Discussion
Noxa Induction in Activated T Cells Is Not
Controlled by p53
We applied a novel procedure (RT-MLPA) tailored to
study virtually all direct apoptosis regulators in human
systems, and we observed a hitherto unknown rapid
and sustained upregulation of the BH3-only member
Noxa in activated human T cells, both upon direct TCR
triggering and by common g-chain cytokines IL-7 and
IL-15. Initial reports indicated that both Noxa and
Puma are p53-responsive genes (Nakano and Vousden,
2001; Oda et al., 2000; Villunger et al., 2003; Shibue et al.,
2003; Yakovlev et al., 2004; Seo et al., 2003). Currently,
the mechanism that regulates Noxa expression is not
completely understood, as the p53 dependency ap-
pears to vary in different human cell types (Kim et al.,
2004; Flinterman et al., 2004; Qin et al., 2004). Our anal-
ysis clearly showed that Noxa mRNA expression was
not under control of p53 in human T cells. Noxa expres-
sion was neither induced after g-irradiation nor altered in
p53-deficient T cells upon TCR triggering (Figure 3). In
addition, Noxa RNAi in primary T cells did not affect
radiation-induced apoptosis (Figure 6). In contrast, p53
activation seems to suffice for Puma induction, although
it can also be regulated in a p53-independent fashion
(Villunger et al., 2003).
Although results obtained with pharmacological in-
hibitors should be considered with caution in view of un-
specified effects, a tentative interpretation of our data
indicates that TCR-induced Noxa expression might in-
volve PKC (Figure 2). The same pathway was proposed
elsewhere to be involved in Bim upregulation in chroni-
cally activated T cells (Sandalova et al., 2004), as op-
posed to freshly isolated cells. This is in agreement
with our findings and with data reported previously
that Bim is not transcriptionally regulated in mouse acti-
vated CD8+ T cells in vivo (Hildeman et al., 2002).
Function of Noxa in Selective Elimination of Dividing
T Lymphocytes in Glucose-Deprived Conditions
Glucose is a pivotal nutrient to fulfill the metabolic re-
quirements of highly proliferative cells. In lymphocytes,
Glut1 is the main glucose transporter, and its expression
is enhanced by Akt/PKB (Frauwirth et al., 2002; Frau-
wirth and Thompson, 2004). In Jurkat cells, Akt/PKB
is constitutively active due to a defect in PTEN expres-
sion, thereby contributing to an elevated glucose uptake
and metabolism (Shan et al., 2000). At high cell density
and reduced availability of glucose, lymphocytes are
doomed to die (Rathmell et al., 2000; Vander Heiden
et al., 2001). Our data indicate that under these condi-
tions, the Noxa/Mcl-1 axis is functionally involved inapoptosis of dividing leukemic but also in primary lym-
phocytes. The observation that addition of glucose not
only delayed the onset of apoptosis but also maintained
the survival advantage of cells with low Noxa supports
this conclusion (Figures 5 and 7).
How exactly decreasing glucose levels couple to the
apoptotic machinery is presently unknown. Under these
circumstances, a decline in intracellular glucose metab-
olism occurs with a subsequent alteration on ATP/ADP
ratio (Plas et al., 2002). It is known that overexpression
of Bcl-xl prevents apoptosis induced by glucose with-
drawal (Vander Heiden et al., 1999). Thus, an obvious
hypothesis is that a drop in glycolytic messengers trig-
gers directly the activity of proapoptotic Bcl-2 proteins
(Vander Heiden et al., 2001; Plas et al., 2002). Alterna-
tively, and in agreement with more recent reports (Willis
et al., 2005; Zhong et al., 2005), we favor that this activa-
tion is caused by limiting levels of prosurvival members,
such as Mcl-1, that keep proapoptotic members on
a leash. The importance of Mcl-1 in development and
survival of lymphocytes is now well known (Opferman
et al., 2003). Recently, it was reported that in HeLa cells
that overexpress Noxa, Bak is displaced from Mcl-1 and
thereby Bak can become activated. Moreover, the asso-
ciation with Noxa targets Mcl-1 for degradation (Willis
et al., 2005). In healthy cells, we have found no evidence
that reduction in Noxa protein via RNAi affects Mcl-1
levels, but under conditions of limited glucose, Noxa
levels influence Mcl-1 degradation (Figure 7C). In the
complementary situation, a reduction of Mcl-1 protein
by RNAi renders cells more susceptible to apoptosis
by glucose shortage. Mcl-1 has a broad interaction
range with various BH3-only members (e.g., Bim, see
also Figure 7A), while Noxa has restricted interaction
(Chen et al., 2005; Willis et al., 2005). Therefore, it may
be expected that Mcl-1, in contrast to Noxa, affects dis-
tinct apoptosis pathways, and this is indeed what we
found in preliminary experiments (data not shown).
Both Mcl-1 and Noxa appear to reside at the mitochon-
dria (Figure 7) or other cellular compartments that may
contaminate the heavy membrane fraction. A drop in glu-
cose metabolism may directly or indirectly expose the
Mcl-1-Noxa complex in the outer mitochondrial mem-
brane to the protein degradation machinery. A novel E3
ubiquitin ligase (Mule) has been identified recently that
specifically regulates degradation of Mcl-1 (Zhong
et al., 2005). It could be that Mule, which in fact contains
a BH3-only domain that may facilitate association with
other mitochondrial proteins, responds to decreasing
glucose levels and targets Mcl-1 for degradation.
How Do T Cells Actually Die?
Compelling evidence suggests that BH3-only proteins
Bim and Bid directly interact with multidomain apopto-
genic Bax and Bak, whereas all other BH3-only proteins
tested to date, including Noxa, are clustered as antago-
nists of antiapoptotic proteins (Kuwana et al., 2005;
Chen et al., 2005). Moreover, distinct BH3-only proteins
possess differential binding to prosurvival Bcl-2 pro-
teins (Letai et al., 2002; Chen et al., 2005; Kuwana
et al., 2005). In particular, Noxa associated preferentially
with Bfl-1 or Mcl-1 in concordance with our data (Fig-
ure 7). The presumed direct proapoptotic activity in prior
reports (Oda et al., 2000; Shibue et al., 2003; Seo et al.,
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712Figure 7. Role of Noxa in T Cell Apoptosis Becomes Apparent when Mcl-1 Levels Decrease
(A) In healthy Jurkat cells, Noxa is bound to Mcl-1. Protein lysates were subjected to immunoprecipitation (IP) reactions by anti-Mcl1 or control
Ab to evaluate the association of Noxa with Mcl-1 (left). Middle: 5% lysates after IP; right: 5% of total protein lysates, analyzed by Western
blotting. The membrane was rehybridized with anti-Bim and anti-b-actin as positive and negative control for the IP, respectively.
(B) Noxa and Mcl-1 are present in the mitochondria-rich fraction. Viable Jurkat cells were separated into heavy membrane-enriched (HM), light
membrane (LM), and cytosol (C) fractions and probed for the indicated proteins.
(C) During glucose-limited conditions, Mcl-1 is degraded, which is prevented if glucose was resupplemented. Mock, N7, N8, transduced Jurkat
cells were cultured in medium supplemented with 25 or 5 mM glucose (6 extra 5 mM on day 2), for 1 week or 4 days, respectively (25 mM top,
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7132003; Kim et al., 2004) can probably also be explained by
the derepressor activity of overexpressed Noxa. Obvi-
ously, despite its marked induction in primary activated
T cells, endogenous Noxa does not cause significant
cell death (Figure 1 and Figure S1). Thus, in line with re-
cent biochemistry data (Chen et al., 2005; Kuwana et al.,
2005), we infer that Noxa plays a regulatory role to inhibit
the prosurvival activity of Mcl-1 and Bfl-1, of which the
latter is also induced upon TCR triggering (Figure 1).
Proapoptotic members are seen as foes for cell survival,
but at the level of the organism, unlicensed survival is
detrimental. Our results indicate that activation of lym-
phocytes either via TCR or cytokine receptors induce
various protective Bcl-2 members. In this setting, tip-
ping the balance toward T cell survival in highly prolifer-
ating cells that receive antigen and/or cytokine signals
and possess DNA recombination activity is harmful
and predisposes to oncogenic transformation or auto-
immunity. Therefore, compensatory mechanisms seem
mandatory to safeguard the organism. For this reason,
Noxa may have evolved as a safety valve to neutralize
protective Mcl-1 and A1/Bfl-1.
It is evident that BH3-only proteins function upstream
of Bax and Bak, which are absolutely required for apo-
ptosis (Wei et al., 2001; Cheng et al., 2001). Bim is
a key player in the death of lymphocytes, purportedly
by directly activating Bax and Bak (Zhu et al., 2004; Hil-
deman et al., 2002; Pellegrini et al., 2003). We propose
that different regulatory or derepressor BH3-only mem-
bers (Puma, Bad, Noxa, Bik), at distinct stages of lym-
phocyte life span, contribute indirectly to Bim activation
through their function as deposits of protective mem-
bers. A secondary role for Bik and Noxa is underscored
by the absence of an overt phenotype of the respective
KO mice (Villunger et al., 2003; Shibue et al., 2003; Coul-
tas et al., 2004; Erlacher et al., 2005). Interestingly, the
mouse Noxa protein differs from the human in that it
contains a unique double BH3-only domain (Oda et al.,
2000), and this interspecies variation may influence pro-
tein function. Our preliminary data indicate that mouse
Noxa is also upregulated upon peripheral T cell activa-
tion, but thymic T cells may respond differently in mouse
and human (data not shown). Previous studies on
Noxa2/2 mice addressed mainly p53- or stress-induced
apoptosis and did not incorporate T cell stimuli (Shibue
et al., 2003; Villunger et al., 2003; Erlacher et al., 2005).
Therefore, a thorough comparison of Noxa gene regula-
tion and protein function is currently warranted in order
to establish whether Noxa in activated murine lympho-
cytes also functions in apoptosis provoked by glucose
deprivation.
Conceptual models proposed that different environ-
mental clues will activate cell death through distinct
BH3-only proteins in different cell types (Puthalakath
and Strasser, 2002; Danial and Korsmeyer, 2004), al-
though the orchestrated activity of more than one BH3-only protein should also be considered. Accordingly, cy-
tokine withdrawal induces cell death in a Bim-dependent
manner, Bid is activated by caspase-8-mediated prote-
olysis after death receptor triggering, and HRK and
Bad seem to initiate growth-factor-withdrawal-induced
cell death in neurons and hematopoietic mammary
epithelial cells and fibroblasts (Strasser, 2005). In p53-
mediated responses, Puma is the key BH3-only member
initiating the apoptotic cascade (Villunger et al., 2003).
Our data shed light on a hitherto undefined role of Noxa
in cell death of dividing lymphocytes. We propose that
the Noxa/Mcl-1 pair may have a general function as rheo-
stat under conditions of glucose deprivation. In this
capacity, the Noxa/Mcl-1 axis presumably functions
also in nonlymphoid cells and/or in pathological circum-
stances when cells compete for nutrients.
Experimental Procedures
Cell Preparation, Cell Lines, and Flow Cytometry
Umbilical cord blood mononuclear cells (UCBMC) or peripheral
blood mononuclear cells (PBMC) were isolated by Ficoll-Isopaque
density gradient centrifugation (Nycomed, Pharma, Oslo, Norway).
Naive CD8+ T cells were purified from UCBMC by positive selection
via the MACS system, as described previously (Alves et al., 2003).
Naive CD4+ T cells were purified from adult PBMC, by negative de-
pletion, as described previously (Hamann et al., 1996). The sample
purity was assessed by FACS (Becton Dickinson), with FITC-conju-
gated CD27 (CLB-CD27/2), PE-conjugated CD45RA, PerCP-conju-
gated CD8 or PerCP-conjugated CD4, and APC-conjugated CD3
mAb from Becton Dickinson (San Jose, CA) (purity: >95% CD3+
CD8+ or CD4+ CD27+ CD45RA+).
The J16 clone was derived from the human T acute lymphoblastic
leukemia cell line Jurkat by limiting dilution and was selected for
CD95 sensitivity (Boesen-de Cock et al., 1999; Werner et al., 2002).
CFSE Labeling and Cell Culture
Purified naive T cells were pelleted and resuspended in PBS at a final
concentration of 5–10 3 106 cells/mL. Next, cells were labeled with
2.5 mM (final concentration) of 5-(and-6)-Carboxyfluorescein Diace-
tate Succinimidyl Ester (CFSE; Molecular Probes Europe BV, Leiden,
The Netherlands) in PBS for 10 min at 37ºC. Cells were washed and
subsequently resuspended in IMDM supplemented with L-Gluta-
mine, 25 mM HEPES (Biowhittaker Europe), containing 10% Human
Pool Serum (HPS) (Biowhittaker, MD), streptamycin (100 ng/ml)
(GIBCO-BRL, Paisley, Scotland), penicillin (10 U/ml) (Yamanouchi,
Pharma, Leiderdorp, The Netherlands), and 3.57 3 1024% (v/v) b-
mercapto ethanol (Merck, Darmstadt, Germany), used as standard
culture medium. DMEM without glucose was purchased from
GIBCO (Paisley, Scotland, UK) and supplemented by addition of
glucose (Merck).
For stimulation of T cells with anti-CD3 mAb, tissue-culture plates
were coated overnight at 4ºC with 1mg/ml of the CD3 mAb (CLB-T3/3)
in PBS. After overnight incubations, coating solutions were removed,
and plates were washed gently with 13 PBS to remove unbound Ab.
T cells were added to separate Ab-coated plates for 24, 72, 120 hr
activation. T cells were stimulated with a combination of plate
bound anti-CD3 mAb in the presence or absence of soluble CD28
mAb (5mg/ml) (CLB-CD28/1). CD8+ T cells were stimulated with Phor-
bol myristate acetate (PMA 1 ng/ml), ionomycin (1 mg/ml) for 4 hr
(all from Sigma). For stimulation with cytokines, naive T cells were
cultured in presence or absence of IL-7 (Strahtmann, Germany),5 mM bottom). At designated time points, Noxa and Mcl-1 protein levels were analyzed by Western blotting. Numbers below the lanes indicate
the percentage of viable cells simultaneously determined by FACS analysis.
(D) Reduction in Mcl-1 levels renders cells susceptible to apoptosis in glucose-limited conditions. (i) Mcl-1 knockdown was obtained by two
different Mcl-1 siRNA constructs. Jurkat T cell line was transduced with pRetro-control GFP (M), pRetro-GFPsiMCL-1.1 (Mcl1i1), and pRetro-
GFPsiMcl-1.3 (Mcl1i3). J16 (untransduced cells). (ii) Survival of Mcl-1 low (Mcl-1i1-GFP+) and Mcl-1 high (J16-GFP2) cells during growth. Cell
viability was measured as described in Figure 5: J16 (circles) and Mcl-1i1 (diamonds) cells. (iii) In similar experiments as described in Figure 5,
the ratio between transduced (GFP+) and untransduced (GFP2) cells was calculated in the live gating, M (M:J16) (circles), Mcl1i1 (Mcl1i1:J16)
(diamonds), and Mcl1i3 (Mcl1i3:J16) (triangles). Data represent mean 6 SD from three experiments.
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714IL-15 (R&D systems, Minneapolis, MN). Cells were cultured in culture
medium at 37ºC in 5% CO2 atmosphere.
Detection of Apoptotic Cells
The viability of cells was analyzed by FACS for primary T cells
through T cell activation period and before or 24 hr after g-irradiation
(3000 Rad) and for J16 cells after culture with various death stimuli.
In brief, cells were harvested and washed in ice-cold HEPES buffer
(10 mM HEPES, 150 mM KCl, 1 mM MgCl2, and 1.3 mM CaCl2 [pH
7.4]). Cells were then incubated with APC-labeled Annexin-V (IQ
Products, Groningen, The Netherlands) for 20 min. Just before anal-
yses of the samples by FACS, propidium iodide (PI) (Sigma, St.
Louis, MO) was added (final concentration 5 mg/ml). Viable cells
were defined by Annexin V2/PI2 staining. Cells were also incubated
with Mitotracker (200 nM; Molecular Probes) for 30 min at 37ºC,
washed, and double stained with Annexin V-APC.
Reagents
A panel of different chemical drugs was used to block different intra-
cellular signaling components: PD98059 (10 mM), SB202190 (10 mM),
LY294002 (10 mM) (all from Calbiochem, San Diego, CA); cyclospor-
ine (500 ng/ml), NFkBay (20 mM), staurosporine (10 nM), bisindolyl-
maledeide (BIM) (0.2 mM), and rottlerin (10 mM) were purchased
from Sigma. A panel of different stimuli was used to induce apopto-
sis: fludarabine, etoposide, thapsigargin, carbonyl cyanide m-chlor-
ophenylhydrazone (CCCP), and taxol were obtained from Sigma.
H2O2 was purchased from Lommerse Pharma (Oss, The Nether-
lands). Fas10 mAb (agonistic antibodies to the CD95 receptor) and
Fas 2 mAb (blocking antibodies to the CD95 receptor) were a kind
gift from Prof. Dr. L. Aarden (CLB, Amsterdam, The Netherlands).
RT-PCR Analyses
Total RNA was extracted with GeneElute Mammalian total RNA mini-
prep kit (SIGMA), and cDNA was synthesized by means of oligodeox-
ythymidine (oligo(dT)) and Superscript II RNase H-reverse transcrip-
tase (Invitrogen Life Technologies, Carlsbad, CA). Noxa transcripts
were amplified by polymerase chain reaction (PCR) (50-CCTGGGAA
GAAGGCGCG-30 and 50-TCAGGTTCCTGTGCAGAAG -30), and prod-
ucts were electrophoresed on 1% agarose gels.
RT-MLPA Procedure and Analysis
MLPA (multiplex ligation-dependent amplification) probes consist of
two oligonucleotides that anneal to adjacent sites on a target se-
quence and are then ligated by a heat stable ligase. Each ligated
probe gives rise to an amplification product of unique length, and
the resulting DNA mixture is analyzed by capillary sequencer and
standard software for identification and relative quantification of
the amplicons. Each MLPA probe consists of one short synthetic
oligonucleotide (Biolegio, Malden, The Netherlands) and one phage
M13-derived long probe oligonucleotide. Preparation of the M13-
derived MLPA probe oligonucleotides and all probes used in the
apoptosis gene probe set, as well as detailed reaction conditions
for RT-MLPA, have been described elsewhere (Eldering et al.,
2003). In brief, RNA samples (40–60 ng of total RNA) were first re-
verse transcribed by means of a gene-specific probe mix. The result-
ing cDNA was annealed overnight at 60ºC to the MLPA probes. An-
nealed oligonucleotides were covalently linked by Ligase-65 at 54ºC
(MRC-Holland). Ligation products were amplified by PCR (33 cycles,
30 s at 95ºC; 30 s at 60ºC; and 1 min at 72ºC) via one unlabeled and
one FAM labeled primer (10 pMol). After the PCR stage, aliquots of
samples were mixed with Genescan-500 ROX size standards and
run on an ABI 3100 capillary sequencer (Applied Biosystems, War-
rington, UK) in Genescan mode.
Data were analyzed with Genescan and compiled in table format
with Genotyper (ABI) and exported for further analysis with Micro-
soft Excel spreadsheet software. The sum of all peak data was set
at 100% to normalize for fluctuations in total signal between sam-
ples, and individual peaks were calculated relative to the 100%
value. Signals below the detection limit in medium were assigned
a value corresponding to the threshold value for noise cut-off in Gen-
escan. Gene expression levels were calculated relative to unstimu-
lated cells at t = 24 hr, which was set at 1. The logarithm (base 2)
of the resulting data sets were imported in the TIGR Multiexperiment
viewer version 2.2 (http://www.tigr.org/software/tm4).SDS-Page, Western Blotting, and Immunoprecipitation
After washing with ice-cold PBS, cells were lysed in lysis buffer (1%
NonidetP-40, 0.001 M triethanollamine-Hcl [pH 7.8], 0.15 M NaCl,
5 mM EDTA, 0.02 mg/ml ovomucoid trypsin inhibitor, 1 mM PMSF,
and 0.02 mg/ml leupeptin). After 15 min on ice, lysates were cleared
by centrifugation at 13,000 rpm for 15 min. Protein contents were
determined by the Bio-Rad protein assay (Bio-Rad Laboratories,
Munchen, Germany). Depending on the protein detected, 30 to 50
mg of protein per lane was separated by SDS-PAGE (13%) and trans-
ferred to nitrocellulose membranes (Hybond-C, Amersham, Buck-
inghamshire, UK). Proteins were visualized by staining the blots
with anti-Noxa Biocarta (Carlsbad, CA), Mcl-1 (BD Pharmingen),
Bim (Stressgen, Canada), Bak and porin (Calbiochem), and b-actin
(Santa Cruz Biotechnology, Santa Cruz, CA), and antisera against
Bid was a kind gift of Prof. Dr. J. Borst (NKI, The Netherlands). Sub-
cellular fractionation was done as described (Gomez-Bougie et al.,
2005). The obtained heavy membrane, light membrane, and cyto-
solic fractions were analyzed by SDS-PAGE and Western blot.
For immunoprecipitation, 50 3 106 cells were lysed in 1% Triton-
x100-containing lysis buffer. Whole-cell lysates were precleared
with normal rabbit serum precoupled to protein A-sepharose and
then incubated for 3 hr with 5 mg of Mcl-1 antibody (BD Pharmingen)
precoupled to protein A-Sepharose. Beads were pelleted, washed
six times, and boiled in SDS sample buffer. The presence of immune
complexes was determined by Western blot analysis.
Retroviral Constructs and Retroviral Infection
To knock down p53, we used pTRIPDU3-E1a vector containing the
human p53 targeting sequence 50GACTCCAGTGGTAATCTAC (Gi-
meno et al., 2004). To knock down Noxa and Mcl-1, we used pRe-
tro-super vector, adapted from pSuper construct (Brummelkamp
et al., 2002), containing the polymerase III H1-RNA promoter (pol3)
for the transcription of the siRNA probe and the phosphoglycerin ki-
nase (pgk)1 promoter driving GFP expression in opposite directions.
The siRNA sequences specifically targeting Noxa mRNA were the
following: N7 50-GAAGGTGCATTCATGGGTG-30, N8 50-GTAATT
ATTGACACATTTC-30. The siRNA sequences specifically targeting
Mcl-1 mRNA, described previously (Nencioni et al., 2005), were the
following: Mcl-1i1 50-GCAGTCCTCTAGTGTTTCA-30, Mcl-1i3 50-
GGAGTATGCTCACTTAAAT-30. The retroviral plasmids were trans-
fected into the helper virus-free amphotropic producer cell line
Phoenix with Fugene-6 (Roche Diagnostics Netherlands), according
to manufacturer’s protocol.
Transduction of total T cells, CD8+ T cells, or J16 cells was per-
formed according to standard protocols, as described previously
(Gimeno et al., 2004). In brief, transduction of cells was performed
by 1 cycle of overnight exposure to viral supernatant (containing
mock vector, p53 RNAi-targeting sequence, or two Noxa or two
Mcl-1 RNAi-targeting sequence) on retronectin (Takara Shuzo,
Otsu, Japan)-coated 24-well plates. The efficiency of transduction
was estimated by determining the percentage of green fluorescence
protein (GFP)-positive cells, 2 to 3 days later, by flow cytometry.
GFP-positive cells were sorted on a FACS sorter for further experi-
ments (Moflow; Dako-Cytomation, Carpinteria, CA), to >90% purity
assessed by FACS. To improve knockdown of Noxa in Jurkat, a
limiting dilution of the N8 population was performed according to
standard procedures. Resulting clones were selected for increased
resistance to Velcade and further characterized by Western blot and
RT-MLPA to assess reduced Noxa expression.
After sorting, 0.1–0.4 3 10e6 primary transduced T cells were ob-
tained based on GFP expression. To obtain adequate cell numbers
for functional experiments, cells were subsequently expanded for 1
week by culturing with PHA (1 mg/ml) in the presence of IL-2 (25 U/ml)
and feeders cells (13 10e6 irradiated PBMCs from 3 pooled donors).
After expansion, cell yields varied between 1 and 2 3 10e6 cells per
condition (Mock or Noxi8). Before functional experiments were con-
ducted, cells were subjected to Ficoll-Isopaque density gradient
centrifugation to ensure starting cell populations with viability above
85%. Final cell yields were 0.5–1.5 3 10e6.
Supplemental Data
The five supplemental figures can be found with this article online at
http://www.immunity.com/cgi/content/full/24/6/703/DC1/.
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